SYDNEY (Reuters) - Australia abruptly halted the production of a home-made vaccine against COVID-19 after trials showed it could interfere with HIV diagnosis, the developers said, with the government instead securing additional doses of rival vaccines.
The inoculation being developed by the University of Queensland (UQ) and vaccine maker CSL, one of four candidates contracted by the Australian government, was halted after "certain HIV diagnostic assays" returned false positives.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
